Commissioner Von Eschenbach: NCI Director Named Acting Head Of FDA
This article was originally published in The Tan Sheet
Executive Summary
National Cancer Institute Director Andrew von Eschenbach, MD, brings extensive scientific expertise and experience working with Congress as the head of a high-profile federal agency to the role of FDA commissioner